Tocilizumab-Based Treatment of Microvascular Inflammation in Kidney Transplant Recipients: A Retrospective Study
Chronic-active antibody mediated rejection (caAMR) is the leading causes of long-term kidney graft failure. Tocilizumab (TCZ), an anti-IL-6 receptor antibody, has been suggested as a treatment, but data are conflicting. We retrospectively studied consecutive adult kidney transplant recipients with c...
Saved in:
| Main Authors: | Johan Noble, Giorgia Comai, Valeria Corredetti, Reda Laamech, Celine Dard, Thomas Jouve, Diane Giovannini, Audrey Le Gouellec, Shivani Wadnerkar, Paolo Cravedi, Della Apuzzo, Daniele Vetrano, Marco Busutti, Chiara Abenavoli, Paolo Malvezzi, Lionel PE Rostaing, Gaetano Lamanna |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Transplant International |
| Subjects: | |
| Online Access: | https://www.frontierspartnerships.org/articles/10.3389/ti.2025.14502/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Kidney transplant outcomes in HLA desensitized patients with pretransplant CDC and/or FCM positive crossmatches
by: Johan Noble, et al.
Published: (2025-06-01) -
Belatacept in Kidney Transplantation: Reflecting on the Past, Shaping the Future
by: Johan Noble, et al.
Published: (2025-05-01) -
Response to “A Caution Against the Use of C5B-9 Endothelial Assay to Support Eculizumab Therapy”
by: Federica Maritati, et al.
Published: (2024-05-01) -
Tuning antibody stability and function by rational designs of framework mutations
by: Joseph C. F. Ng, et al.
Published: (2025-12-01) -
Immunoadsorption and Plasma Exchange are Comparable in Anti-Neutrophil Cytoplasmic Antibodies or Anti-Glomerular Basement Membrane Removal Kinetics
by: Marion Sallee, et al.
Published: (2024-09-01)